Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid-Reference-Cited by-同舟云学术

Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid

Published:2003-01 Issue:5 Volume:278 Page:2777-2780
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Shaw-Reid Cathryn A.,Munshi Vandna,Graham Pia,Wolfe Abigail,Witmer Marc,Danzeisen Renee,Olsen David B.,Carroll Steven S.,Embrey Mark,Wai John S.,Miller Michael D.,Cole James L.,Hazuda Daria J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference24 articles.

1. Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.

2. Gene Regulation and AIDS: Transcriptional Activation, Retroviruses, and Pathogenesis;Schatz,1989

3. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function

4. Inhibitors of HIV- I reverse transcriptase

5. Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and anti-inflammatory activity of N-arylamides of 4-aryl- and 4-(thiophen-2-yl)-2-[2-(furan-2-carbonyl)hydrazono]-4-oxobutanoic acids;Russian Chemical Bulletin;2023-09

2. Targeting Ribonucleases with Small Molecules and Bifunctional Molecules;ACS Chemical Biology;2023-06-29

3. The Categories, Mechanisms and Features of Nonnucleoside Reverse Transcriptase Inhibitors of HIV-1;Highlights in Science, Engineering and Technology;2023-03-21

4. Computational and Crystallographic Analysis of Binding Structures of Inhibitory Compounds for HIV-1 RNase H Activity;Journal of Chemical Information and Modeling;2022-10-03

5. Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications;Pharmaceuticals;2022-08-31